Lyell Immunopharma, Inc. (LYEL)
NASDAQ: LYEL · Real-Time Price · USD
23.83
-0.01 (-0.04%)
Apr 16, 2026, 10:05 AM EDT - Market open
Lyell Immunopharma Market Cap
Lyell Immunopharma has a market cap or net worth of $555.92 million as of April 16, 2026. Its market cap has increased by 247.93% in one year.
Market Cap
555.92M
Enterprise Value
359.92M
1-Year Change
247.93%
Ranking
Category
Stock Price
$23.83
Market Cap Chart
Since the IPO on June 17, 2021, Lyell Immunopharma's market cap has decreased from $4.13B to $555.92M, a decrease of -86.53%. That is a compound annual growth rate of -33.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 14, 2026 | 545.18M | -16.62% |
| Dec 31, 2025 | 653.89M | 249.70% |
| Dec 31, 2024 | 186.98M | -61.73% |
| Dec 29, 2023 | 488.63M | -43.52% |
| Dec 30, 2022 | 865.16M | -53.52% |
| Dec 31, 2021 | 1.86B | -54.91% |
| Jun 17, 2021 | 4.13B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CorMedix | 571.53M |
| Kyverna Therapeutics | 568.28M |
| Tectonic Therapeutic | 557.48M |
| Verastem | 556.05M |
| ADC Therapeutics | 555.18M |
| Fulcrum Therapeutics | 549.45M |
| Aclaris Therapeutics | 546.25M |
| Shattuck Labs | 541.92M |